Tag: Kevzara (sarilumab)
Sanofi and Regeneron provide update on Kevzara Phase 3 Covid-19 trials
Sanofi and Regeneron Pharmaceuticals announced that the US Phase 3 trial of Kevzara (sarilumab) 400 mg in Covid-19 patients requiring mechanical ventilation did not...